WNTresearch - WNT research

WNT research

WntResearch
Pipeline
Investor
NEWS
- Press Releases
- Subscribe
Corporate Governance
Contact

Management

WNTresearch → Management

Management

Pernilla Sandwall, CEO

Klaus Christensen, CCO

Dennis Henriksen, CTO

Kicki Johansson, COO

Anders Tidfors, CFO

A new approach to fight tumour spread!
Foxy-5 is a unique drug candidate:
Significant medical need, first-in-class, unique mode of action, excellent pharmacokinetics, strong preclinical efficacy data, favourable safety profile

QUICK LINKS

Phase 2 study
Press Releases
shares

Copyright © All rights reserved.